[Other trials with drug therapy in parkinsonism].
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000639:Amitriptyline / Q000627:therapeutic use; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004221:Disulfiram / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010848:Picolinic Acids / Q000627:therapeutic use; D051381:Rats; D012694:Serine / Q000627:therapeutic use; D013997:Time Factors; D014364:Tryptophan / Q000627:therapeutic use; D014443:Tyrosine / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D010848:Picolinic Acids; D000639:Amitriptyline; D014443:Tyrosine; D012694:Serine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D007099:Imipramine; D004221:Disulfiram
Andre forsøk på medikamentell behandling av parkinsonisme.